Measurement of portal pressure and its role in the management of chronic liver disease.
about
Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond.Cancer and liver cirrhosis: implications on prognosis and managementHepatic Venous Waveform, Splenoportal and Damping Index in Liver Cirrhosis: Correlation with Child Pugh's Score and Oesophageal VaricesLiver ultrasound elastography: More than staging the disease.Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient.A new sampling method for spleen stiffness measurement based on quantitative acoustic radiation force impulse elastography for noninvasive assessment of esophageal varices in newly diagnosed HCV-related cirrhosis.Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis.Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension.Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.Probe-based confocal laser endomicroscopy quantitative morphometric markers associated with portal hypertension in duodenal mucosa.Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic FeaturesThe VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.After proper optimization of carvedilol dose, do different child classes of liver disease differ in terms of dose tolerance and response on a chronic basis?Contrast-enhanced ultrasound evaluation of hepatic microvascular changes in liver diseases.Hepatic venous pressure gradient is a useful predictor in guiding treatment on prevention of variceal rebleeding in cirrhosis.EUS-guided portal pressure measurement using a digital pressure wire with real-time remote display: a novel, minimally invasive technique for direct measurement in an animal model.The risk factors for bleeding of fundal varices in patients with liver cirrhosis.Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension.Hepatic venous pressure gradient: clinical use in chronic liver disease.Indications for portal pressure measurement in chronic liver disease.Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.The interpretation of hepatic venous pressure gradient tracings - excellent interobserver agreement unrelated to experience.Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.EUS-guided intrahepatic portosystemic shunt with direct portal pressure measurements: a novel alternative to transjugular intrahepatic portosystemic shunting.(99m)Tc-phytate trans-splenic portal scintigraphy in the diagnosis of cirrhotic portal hypertension and compensatory circulation.[Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].Reversal of liver fibrosis.NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study.Cardiovascular risk factors and systemic endothelial function in patients with cirrhosis.Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis.Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension.Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study.Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis.von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension.Hepatic Vein Arrival Time for Diagnosis of Liver Cirrhosis: A 10-Year Single-Center Experience With Contrast-Enhanced Sonography.Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient.von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis.
P2860
Q26853160-881044E0-BB31-438B-BD2A-4EEF76645C5EQ28068579-815AE27C-BB7C-4D0A-A75D-5C9E0F96BE6AQ30387141-9A39D79C-7219-4C24-AF92-53AB260BBBFFQ30407629-9B99AEE2-A4BA-4A27-A44A-A391004E9ABCQ30433926-911559E3-B37F-4545-BA09-43B0B79A351AQ30440198-8C6F91C9-BC52-4A57-9870-E4C9FB2F532AQ33400782-C715C1EF-0BC2-45BB-99F6-2B39874D23A8Q34631908-1A976B59-E9C1-4629-8982-66291F06CB25Q35237338-11BE87E5-64CD-45A4-A3DB-E004862F85A4Q35680561-F9B713A4-216C-4049-BEB5-7EDB57090CE0Q35850234-BE2A4B01-2B5F-48B4-8FF6-F3AB61A3809AQ35928746-926AA3DC-F6A7-4920-9316-71A6F5051DABQ36246310-A38E5C69-1B69-4F4A-A325-4147BFCC04B0Q36310433-6ECC0F09-D0DB-4208-91A2-AA370F704B10Q36412440-441607B9-19DA-4369-93BF-A48ECBC39B61Q36848204-99C6BC4C-7477-4B66-B972-12997F17AB68Q37359394-F03A64AE-0142-4105-ACD7-38ED8F40C0B0Q37651909-B761D676-67D5-4252-B30A-C73B8AEAA5F3Q37711328-328561C5-9461-4B49-9EEC-F79210744F3AQ38027225-8BB88C9E-229F-477F-A460-5F0E7D1BC589Q38618343-A7A10958-4245-4DBD-8F0B-840CC0CF125AQ40111415-AC821942-521E-43B6-80FD-76EF8CE2C06DQ40291409-12ADA07F-7A4F-4FA6-9268-D8500E1867C5Q40393613-D2CD99CD-9359-4DA9-9695-B2192617EF00Q42202787-317C176E-B002-4E57-BE9F-1A8505C27F01Q42757195-27ADFAD9-F342-44B4-AC87-0AA490896C76Q43104809-8B6229BC-A74C-4A01-9CC9-0680B9D25D69Q43240136-E6B9ECCD-DDDC-4CFA-9EA0-404C32AF5F8CQ43874129-2F2B430B-B226-449F-82FD-697034945F2FQ45354653-55532DAD-3296-4038-B7AD-2EAA8DE61C0DQ48258973-D7DA60EA-8EA1-46CD-8838-817BD0868F5FQ48363240-46DE155B-7EA1-436A-92B8-72A9F0474FE5Q50442755-6631B68F-D7DE-4BF6-9148-15FAF9506D8BQ50576256-B28EEA64-CEB0-4F92-98CD-8A60A074FFBAQ50649570-02CB6D70-B035-4EC1-AAC4-5C529CC1438BQ51344051-C21F7E19-89A3-4354-B968-BE1586B12235Q51394345-9E9C2232-B6D6-41C9-B2B5-AD9270E502BFQ52977976-DE5EBF5B-C478-4CAD-A1AB-0C087588A15EQ53339536-977A9119-CF8A-45C9-B694-B9B8F0D352FFQ53543540-FF2B2965-F611-49F3-B53F-F7C14AB12F59
P2860
Measurement of portal pressure and its role in the management of chronic liver disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Measurement of portal pressure and its role in the management of chronic liver disease.
@ast
Measurement of portal pressure and its role in the management of chronic liver disease.
@en
type
label
Measurement of portal pressure and its role in the management of chronic liver disease.
@ast
Measurement of portal pressure and its role in the management of chronic liver disease.
@en
prefLabel
Measurement of portal pressure and its role in the management of chronic liver disease.
@ast
Measurement of portal pressure and its role in the management of chronic liver disease.
@en
P2093
P356
P1476
Measurement of portal pressure and its role in the management of chronic liver disease
@en
P2093
Annalisa Berzigotti
Jaime Bosch
Juan G Abraldes
P304
P356
10.1055/S-2006-951603
P577
2006-11-01T00:00:00Z